advanced lung adenocarcinoma - Globe Thesis

Keyword [advanced lung adenocarcinoma] Result: 21 - 40 \| Page: 2 of 7
21.	Clinical Observation Of Pemetrexed Plus Cisplatin And Docetaxel Plus Cisplatin In Chemotherapy-naive Patients With Advanced Lung Adenocarcinoma
22.	Effect Of Serum CEA Level EGFR Mutation Status On Chemotherapy Efficacy Of No-smokers Advanced Lung Adenocarcinoma
23.	Pemetrexed Plus Platinum As First-line Treatment For Advanced Lung Adenocarcinoma
24.	The Significance Of T Lymphocyte Subsets And CEA In Advanced Lung Adenocarcinoma Curative Effect Evaluation
25.	Analysis Of The Correlation Of Efficacy And Adverse Reactions About Docetaxel And Platinum Agents Treated With Advanced Lung Adenocarcinoma
26.	The Clinical Efficacy Observation Of Lung Tumor Inhibition Cream Combined With DC-CIK Cells On Advanced Lung Adenocarcinoma And The Exploration Of The Corresponding Mechanism In Cell Apoptosis
27.	Lung Tumor Suppression Cream Joint DC-CIK Cells For Advanced Lung Adenocarcinoma Clinical Curative Effect And Its Related Factors Of Apoptosis
28.	The Clinical Observation Of Advanced Lung Adenocarcinoma Of Qi And Yin Deficiency Treated With Qishan Capsule Combined With Pemetrexed And Cisplatin
29.	The Efficacy Comparison Of Icotinib And Gefitinib In Stage â…£ Lung Adenocarcinoma Patients With EGFR Sensitive Gene Mutation
30.	Lung Tumor Extract In Mice With Lewis Lung Cancer With Qi Stagnation Syndrome Of Qi Deficiency And Intervention Model In Patients With Lung Cancer Chemotherapy Effect
31.	Comparison Of Icotinib Versus Docetaxel As Second-line Treatment Of Advanced Lung Adenocarcinoma
32.	The Impact To Prognosis With The Expression Of P53 And PD-L1 In Advanced Lung Adenocarcinoma
33.	Clinical Observation On The Effect Of Lung Tumor Paste Combined With Chemotherapy In The Treatment Of Advanced Lung Adenocarcinoma And The Study On The Intervention Of Lewis Lung Cancer Mice
34.	The Curative Effects Of EGFR-TKIs In Different EGFR Mutation Genotypes And Its Relationship With Expression Of AEG-1 In Advanced Lung Adenocarcinoma
35.	Pemetrexed With Gefitinib Or Pemetrexed Alone In Advanced Lung Adenocarcinoma With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
36.	Clinical Curative Effect Research On Yifei Prescription Combined With Gefitinib In Patients With Advanced Lung Adenocarcinoma
37.	Expression Genetic Polymorphis Of Thymidylate Synthase And Methylene Tetrahydrofolate Reductase In Clinical Research Of Pemetrexed Therapy In Advanced Lung Adenocarcinoma Patients Of High-altitude Areas
38.	Clinical Observation Of Treatment On Advanced Lung Adenocarcinoma With Endostar Deliveried By Different Ways And Chemotherapy
39.	Comparison Of Clinical Characteristics And The Effect Of Gefitinib With Advanced Lung Adenocarcinoma Patients Harbouring EGFR Mutations In Exon 19 And 21
40.	Analyzing EGFR Mutation Status Change In Different Sampling Time-points Of Blood Within One Day In Advanced Lung Adenocarcinoma
<<First <Prev Next> Last>> Jump to